Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    July 2018
  1. PERRICONE G, Vangeli M
    Pyoderma Gangrenosum in Ulcerative Colitis.
    N Engl J Med. 2018;379:e7.
    PubMed     Text format    


    March 2018
  2. ARD KL, Kelly HR, Gandhi RT, Louissaint A Jr., et al
    Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.
    N Engl J Med. 2018;378:1143-1152.
    PubMed     Text format    


    February 2018
  3. KNUESEL SJ, Guseh JS 2nd, Karp Leaf R, Ciaranello AL, et al
    Case 6-2018: A 35-Year-Old Woman with Headache, Subjective Fever, and Anemia.
    N Engl J Med. 2018;378:753-760.
    PubMed     Text format    


    August 2017
  4. KANNEGANTI TD
    Inflammatory Bowel Disease and the NLRP3 Inflammasome.
    N Engl J Med. 2017;377:694-696.
    PubMed     Text format    


  5. DAI C, Jiang M, Sun MJ
    Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;377:496.
    PubMed     Text format    



  6. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;377:496-7.
    PubMed     Text format    


    July 2017
  7. DAVID JG
    The Chair Grant.
    N Engl J Med. 2017;377:108-109.
    PubMed     Text format    


    May 2017
  8. ESFAHANI K, Miller WH Jr
    Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
    N Engl J Med. 2017;376:1989-91.
    PubMed     Text format    


  9. MILOSLAVSKY EM, Stone JH, Moy AP
    Case 14-2017 - A 20-Year-Old Man with Pain and Swelling of the Left Calf and a Purpuric Rash
    N Engl J Med. 2017;376:1868-1877.
    PubMed     Text format    


  10. FRIEDMAN S
    Tofacitinib for Ulcerative Colitis - A Promising Step Forward.
    N Engl J Med. 2017;376:1792-1793.
    PubMed     Text format    


  11. SANDBORN WJ, Su C, Sands BE, D'Haens GR, et al
    Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;376:1723-1736.
    PubMed     Text format     Abstract available


    March 2017
  12. KNIELING F, Neufert C, Hartmann A, Claussen J, et al
    Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity.
    N Engl J Med. 2017;376:1292-1294.
    PubMed     Text format    


    November 2016
  13. FEAGAN BG, Sandborn WJ, Gasink C, Jacobstein D, et al
    Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med. 2016;375:1946-1960.
    PubMed     Text format     Abstract available


    August 2016
  14. MUTNEJA HR, Arora S, Vij A
    Ozanimod Treatment for Ulcerative Colitis.
    N Engl J Med. 2016;375:e17.
    PubMed     Text format    


  15. SANDBORN WJ, Feagan BG
    Ozanimod Treatment for Ulcerative Colitis.
    N Engl J Med. 2016;375:e17.
    PubMed     Text format    


  16. ZEIDMAN JA, Shellito PC, Davis BT, Zukerberg LR, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 25-2016. A 33-Year-Old Man with Rectal Pain and Bleeding.
    N Engl J Med. 2016;375:676-82.
    PubMed     Text format    


    June 2016
  17. GORDON KB, Blauvelt A, Papp KA, Langley RG, et al
    Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  18. SANDBORN WJ, Feagan BG, Wolf DC, D'Haens G, et al
    Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
    N Engl J Med. 2016;374:1754-62.
    PubMed     Text format     Abstract available


    April 2016
  19. SCHWARTZ KR, El Saleeby CM, Nimkin K, Friedmann AM, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 11-2016. A 12-Year-Old Boy with Malaise, Fevers, Abdominal Pain, and Pallor.
    N Engl J Med. 2016;374:1466-76.
    PubMed     Text format    


    February 2016
  20. BILLER JA, Butros SR, Chan-Smutko G, Abrams AN, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 6-2016. A 10-Year-Old Boy with Abdominal Cramping and Fevers.
    N Engl J Med. 2016;374:772-81.
    PubMed     Text format    


    December 2015
  21. BAETEN D, Sieper J, Braun J, Baraliakos X, et al
    Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
    N Engl J Med. 2015;373:2534-48.
    PubMed     Text format     Abstract available


  22. ROSENBAUM JT
    The Immune Response--Learning to Leave Well Enough Alone.
    N Engl J Med. 2015;373:2378-9.
    PubMed     Text format    


  23. JAMES J, Kaul DR, Goldberger ZD, Saint S, et al
    CLINICAL PROBLEM-SOLVING. Back to Nature.
    N Engl J Med. 2015;373:2271-6.
    PubMed     Text format    


    October 2015
  24. SO JK, Paravar T
    IMAGES IN CLINICAL MEDICINE. Sporotrichoid Mycobacterial Infection.
    N Engl J Med. 2015;373:1761.
    PubMed     Text format    


    September 2015
  25. AGUIRRE A, Nugent CA
    Images in Clinical Medicine: Oral Manifestation of Crohn's Disease.
    N Engl J Med. 2015;373:1250.
    PubMed     Text format     Abstract available


    July 2015
  26. LIN YC, Lin YC, Chen CJ
    Cancers Complicating Inflammatory Bowel Disease.
    N Engl J Med. 2015;373:194-5.
    PubMed     Text format    


  27. BEAUGERIE L, Itzkowitz SH
    Cancers Complicating Inflammatory Bowel Disease.
    N Engl J Med. 2015;373:195.
    PubMed     Text format    


    June 2015
  28. KENNEDY BW
    Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.
    N Engl J Med. 2015;372:2461.
    PubMed     Text format    


  29. MONTELEONE G, Pallone F
    Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.
    N Engl J Med. 2015;372:2461.
    PubMed     Text format    


    May 2015
  30. GOEL RM, Hullah E
    Images in clinical medicine. Orofacial fistulae associated with Crohn's disease.
    N Engl J Med. 2015;372:e29.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: